Conceptus (CPTS)
Conceptus Revenues: 29.03M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CPTS Revenues Rankings
| Overall | 27th percentile | 3221 of 4425 |
| Sector | 51st percentile | 228 of 470 in Healthcare |
| Industry | 55th percentile | 30 of 67 in Medical Instruments & Supplies |
CPTS Revenues Range, Past 5 Years
| Minimum | 15.67M | Jun 2007 |
| Maximum | 36.96M | Dec 2009 |
| Average | 29.04M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these CPTS related companies
CPTS News
Market Wrap Video + Additions to Watch List http://stks.co/3iY4 including: $CAR $CPTS $GWR $NVAX $PBY $PPR
about 20 days ago by StockTiger
about 20 days ago by StockTiger
Market Wrap Video + Additions to Watch List http://stks.co/3iAX including: $CAR $CPTS $GWR $NVAX $PBY $PPR
about 20 days ago by StockTiger
about 20 days ago by StockTiger
GARP Research Maintains a 'Buy' on Conceptus (CPTS); Very Attractive Name in Health Care
Apr 30, 3:49PM Street Insider
Apr 30, 3:49PM Street Insider
$CPTS is -7.8% down since open on unusual high volume and -2.8% down since close.
about 28 days ago by TradeBot
about 28 days ago by TradeBot
$CPTS is 5.0% up since open on unusual high volume and 9.9% up since close.
about 31 days ago by TradeBot
about 31 days ago by TradeBot
Listen to $CPTS Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3XQk
about 32 days ago by earningscast
about 32 days ago by earningscast
Conceptus Achieves New Milestone as FDA Approves 10-Year Commercial Data for Essure Label
Apr 11, 9:04AM Benzinga
Apr 11, 9:04AM Benzinga
Conceptus (CPTS) Announces FDA Approved 10-Year Commercial Data for Essure Label
Apr 11, 9:01AM Street Insider
Apr 11, 9:01AM Street Insider
Conceptus(R) Achieves New Milestone as FDA Approves 10-Year Commercial Data for Essure(R) Label
Apr 11, 9:00AM GlobeNewswire
Apr 11, 9:00AM GlobeNewswire
Conceptus(R) to Hold First Quarter Financial Results Conference Call on April 26, 2012
Apr 05, 5:00PM GlobeNewswire
Apr 05, 5:00PM GlobeNewswire
Conceptus(R) Names Lori Ciano as Executive Vice President Human Resources
Mar 26, 5:00PM GlobeNewswire
Mar 26, 5:00PM GlobeNewswire
Conceptus(R) Receives FDA Approval for Compatible Use of Hologic's NovaSure(R) with Essure(R) Inserts in Place
Feb 29, 7:00AM GlobeNewswire
Feb 29, 7:00AM GlobeNewswire
@szaman that reaction to earnings in $CPTS is quite baffling. short sqz as the fuel ?
about 92 days ago by 1nvestor
about 92 days ago by 1nvestor
$CPTS http://stks.co/2YuW Big bounce 20/50 sma.Over 14 for a breakout/ continuation.
about 92 days ago by szaman
about 92 days ago by szaman
Cantor Fitzgerald Raises Price Target on Conceptus (CPTS), Strongly Positioned for Growth
Feb 24, 9:11AM Street Insider
Feb 24, 9:11AM Street Insider
Listen to $CPTS Q4 2011 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2XOF
about 95 days ago by earningscast
about 95 days ago by earningscast
$CPTS Reports Q4 EPS $(0.08) vs $(0.02) Est; Revenues $33.51M vs $33.32M Est
about 95 days ago by Benzinga
about 95 days ago by Benzinga
$CPTS http://stks.co/1ZbN Working on a gap fill. Watching for a continuation.
about 164 days ago by szaman
about 164 days ago by szaman
$CPTS won favorable jury verdict in patent infringement case against $HOLX over its Essure procedure, non-surgical permanent birth control.
about 223 days ago by Shines_Trading_Room
about 223 days ago by Shines_Trading_Room
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CPTS | 16.83 | -0.07 | -0.41% | 526.95M |
| CPT | 65.29 | -0.36 | -0.55% | 5.145B |
| CPHD | 38.47 | +0.38 | +1.00% | 2.519B |
| CPHC | 12.98 | -0.01 | -0.08% | 53.21M |
| CPGI | 0.6344 | -0.08 | -11.79% | 24.61M |
| CPF | 12.92 | +0.04 | +0.31% | 539.41M |
| CPE | 4.54 | -0.08 | -1.73% | 178.92M |
| CPB | 32.58 | +0.02 | +0.06% | 10.31B |
| CPA | 83.85 | +0.62 | +0.74% | 3.713B |
| CLI | 27.14 | -0.22 | -0.80% | 2.383B |